Using room sensors to spot early warnings for hospitalized cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This study uses special sensors in patient rooms to monitor movement and other signals that might show early signs of medical problems. The goal is to see if these sensors can help doctors and nurses step in sooner for cancer patients in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a history of cancer or a current cancer diagnosis.
- You are not receiving comfort or end-of-life care.
- Your primary language is English.
- You are staying in one of the rooms that has the special sensors installed.
- You are NOT in jail or prison.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a wearable activity tracker can help reduce hospitalizations in people undergoing radiation therapy for cancer. Participants will wear a tracker to monitor their activity levels during treatment.
This study tests whether a wearable heart monitor can help detect heart problems early in people receiving cancer treatment. It may help doctors manage heart health during therapy.
This trial tests a system that continuously checks vital signs (like heart rate and breathing) using wireless sensors and sends automatic alerts if you seem to be getting worse. It may help clinicians spot problems sooner whether you’re being monitored at home or around a major surgery hospital stay.
This study tests whether wearing a smartwatch and using an app can help doctors better manage pain and other symptoms in advanced cancer patients. The goal is to catch problems early and improve comfort through better symptom tracking.
This study tests a system that lets you share health information from your phone and wearable device with your care team. It aims to help you get timely support and communication during your cancer treatment.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.